Tryptic amaranth glutelin digests induce endothelial nitric oxide production through inhibition of ACE: Antihypertensive role of amaranth peptides

Nitric Oxide - Biology and Chemistry

Volumn 23, Issue 2, 2010, Pages 106-111

  Barba de la Rosa, A P ^a   Barba Montoya, A ^a   Martínez Cuevas, Pedro ^b   Hernandez Ledesma B ^c   Leon Galvan M F ^a   De Leon Rodriguez A ^a   Gonzalez C ^b  

^a INSTITUTO POTOSINO DE INVESTIGACIÓN CIENTÍFICA Y TECNOLÓGICA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^c INSTITUTO DE FERMENTACIONES INDUSTRIALES CSIC   (Spain)

Author keywords

ACE; Angiotensin converting enzyme inhibition; Antihypertensive plant peptides; Coronary endothelial cells; IC50; Vascular relaxation

Indexed keywords

AMARANTH; ANGIOTENSIN I; ANGIOTENSIN II; BRADYKININ; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; GLUTENIN; NITRIC OXIDE;

ANIMAL CELL; ANTIHYPERTENSIVE ACTIVITY; ARTERY ENDOTHELIUM; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; HYDROLYSIS; IC 50; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RING; VASODILATATION;

AMARANTHUS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA; CELL PROLIFERATION; CELLS, CULTURED; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; GLUTENS; MALE; NITRIC OXIDE; PEPTIDES; PEPTIDYL-DIPEPTIDASE A; PLANT PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRYPSIN;

AMARANTHUS CAUDATUS; RATTUS;

EID: 77954620882     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2010.04.006     Document Type: Article

References (51)

1. Gokce N. L-arginine and hypertension. J. Nutr. 2004, 134:2807S-2811S.
2. Sessa W.C. Regulation of endothelial derived nitric oxide in health and disease. Mem. Inst. Oswaldo Cruz 2005, 1:15-18.
3. Cines D.B., Pollak E.S., Buck C.A., Loscalzo J., Zimmerman G.A., McEver R.P., Pober J.S., Wick T.M., Konkle B.A., Schwartz B.S., Barnathan E.S., McCrae K.R., Hug B.A., Schmidt A.M., Stern D.M. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998, 91:3527-3561.
4. Walford G., Loscalzo J. Nitric oxide in vascular biology. J. Thromb. Haemost. 2003, 1:2112-2118.
5. González C., Corbacho A.M., Eiserich J.P., García C., López-Barrera F., Morales-Tlalpan V., Barajas-Espinosa A., Díaz-Muñoz M., Rubio R., Lin S.-H., de la Escalera G.M., Clapp C. 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation. Endocrinology 2004, 145:5714-5722.
6. Alp N.J., Channon K.M. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler. Thromb. Vasc. Biol. 2004, 24:413-420.
7. Li G.H., Qu M.R., Wan J.Z., You J.M. Antihypertensive effect of rice protein hydrolysate with in vitro angiotensin I-converting enzyme inhibitory activity in spontaneously hypertensive rats. Asia Pac. J. Clin. Nutr. 2007, 16:275-280.
8. Koike H., Ito K., Miyamoto M., Nishino H. Effects of long-term blockade of angiotensin-converting enzyme with captopril (SQ 14, 255) on hemodynamics and circulating blood volume in SHR. Hypertension 1980, 2:229-303.
9. Fleming I. Signaling by the angiotensin-converting enzyme. Circ. Res. 2007, 98:887-896.
10. Ju H., Venema V.J., Marrero M.B., Venema R.C. Inhibitory interactions of the bradykinin B2 receptor with endothelial nitric-oxide synthase. J. Biol. Chem. 1998, 273:24025-24029.
11. Gavras H.P. Issues in hypertension: drug tolerability and special populations. Am. J. Hypertens. 2001, 14:231S-236S.
12. Tom B., Dendorfer A., de Vries R., Saxena P.R., Jan Danser A.H. Bradykinin potentiation by ACE inhibitors: a matter of metabolism. Br. J. Pharmacol. 2002, 137:276-284.
13. Ionescu S.D., Sandru V., Leucic E., Manea P., Burdujan A., Tovarnitch S., Cosovanu A. Undesirable effects and interaction to angiotensin converting enzyme inhibitors therapy. Rev. Med. Chir. Soc. Med. Nat. Iasi 2002, 106:128-131.
14. Meisel H., Goepfert A., Gunther S. ACE-inhibitory activities in milk products. Milchwissenschaft-Milk Sci. Internat. 1997, 52:307-311.
15. Gobbetti M., Ferranti P., Smacchi E., Goffredi F., Addeo F. Production of angiotensin-I-converting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4. Appl. Environ. Microbiol. 2004, 66:3898-3904.
16. Pihlanto-Leppala A., Koskinen P., Piilola K., Tupasela T., Korhonen H. Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides. J. Dairy Res. 2000, 67:53-64.
17. Saito T., Nakamura T., Kitazawa H., Kawai Y., Itoh T. Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese. J. Dairy Sci. 2000, 83:1434-1440.
18. Gomez-Ruiz J.A., Ramos M., Recio I. Angiotensin-converting enzyme-inhibitory peptides in Manchego cheeses manufactured with different starter cultures. Int. Dairy J. 2002, 12:697-706.
19. Hernández-Ledesma B., Recio I., Ramos M., Amigo L. Preparation of ovine y caprine β-lactoglobulin hydrolysates with ACE-inhibitory activity. Identification of active peptides from caprine [beta]-lactoglobulin hydrolysed with thermolysin. Int. Dairy J. 2002, 12:805-812.
20. Motoi H., Kodama T. Isolation y characterization of angiotensin I-converting enzyme inhibitory peptides from wheat gliadin hydrolysate. Nahrung 2003, 47:354-358.
21. Yang Y., Marczak E.D., Usui H., Kawamura Y., Yoshikawa M. Antihypertensive properties of spinach leaf protein digests. J. Agric. Food Chem. 2004, 52:2223-2225.
22. Cha M., Park J.R. Production y characterization of a soy protein-derived angiotensin I-converting enzyme inhibitory hydrolysate. J. Med. Food 2005, 8:305-310.
23. Chen Q., Xuan G., Fu M., He G., Wang W., Zhang H., Ruan H. Effect of angiotensin I-converting enzyme inhibitory peptide from rice dregs protein on antihypertensive activity in spontaneously hypertensive rats. Asia Pac. J. Clin. Nutr. 2007, 16(Suppl. 1):281-285.
24. Cinq-Mars C.D., Li-Chan E.C. Optimizing angiotensin I-converting enzyme inhibitory activity of Pacific hake (Merluccius productus) fillet hydrolysate using response surface methodology y ultrafiltration. J. Agric. Food Chem. 2007, 55:9380-9388.
25. Qian Z.J., Je J.Y., Kim S.K. Anti hypertensive effect of anglotensin I converting enzyme-inhibitory peptide from hydrolysates of bigeye tuna dark muscle, Thunnus obesus. J. Agric. Food Chem. 2007, 55:8398-8403.
26. Barba de la Rosa A.P., Gueguen J., Paredes-López O., Viroben G. Fractionation procedures, electrophoretic characterization and amino acid composition of amaranth seed protein. J. Agric. Food Chem. 1992, 40:931-936.
27. Silva-Sánchez C., Barba de la Rosa A.P., León-Galván M.F., deLumen B.O., De León-Rodríguez A., González de Mejía E. Bioactive peptides in amaranth (Amaranthus hypochondriacuas) seed. J. Agric. Food Chem. 2008, 56:1233-1240.
28. Laemmli Y.K. Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
29. Hernandez-Ledesma B., Martin-Alvarez P.J., Pueyo E. Assessment of the spectrophotometric method for determination of angiotensin-converting-enzyme activity: influence of the inhibition type. J. Agric. Food Chem. 2003, 51:4175-4179.
30. 2+ kinetics in rat coronaryendothelial cells are exerted via aromatization to estrogens. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H63-H71.
31. Kolios G., Valatas V., Manousou P., Xidakis C., Notas G., Kouroumalis E. Nitric oxide and MCP-1 regulation in LPS activated rat Kupffer cells. Mol. Cel. Biochem. 2008, 319:91-98.
32. Miranda K.M., Espey M.G., Wink D.A. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide Biol. Chem. 2001, 5:62-71.
33. García C., Aranda J., Arnold E., Thebault S., Macotela Y., López-Casillas F., Mendoza V., Quiroz-Mercado H., Hernández-Montiel H.L., Lin S.H., de la Escalera G.M., Clapp C. Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A dependent eNOS inactivation. J. Clin. Invest. 2008, 2291-2300.
34. Aoyagi Y. An angiotensin-I converting enzyme inhibitor from buckwheat (Fagopyrum esculentum Moench) flour. Phytochemistry 2006, 67:618-621.
35. Nurminen M.L., Sipola M., Kaarto H., Pihlanto-Leppälä A., Piilola K., Korpela R., Tossavainen O., Korhonen H., Vapaatalo H. Alpha-lactorphin lowers blood pressure measured by radiotelemetry in normontensive and spontaneously hypertensive rats. Life Sci. 2001, 66:1535-1543.
36. Seppo T., Jauhiainen T., Poussa R., Korpela A. Fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am. J. Clin. Nutr. 2003, 77:326-330.
37. Mallikarjun Gouda K.G., Gowdea L.R., Appu Rao A.G., Prakash V. Angiotensin I-converting enzyme inhibitory peptide derived from glycinin, the 11S globulin of soybean (Glycine max). J. Agric. Food Chem. 2006, 54:4568-4573.
38. Wu J., Aluko R.E., Nakai S. Structural requirements of angiotensin I-converting enzyme inhibitory peptides: quantitative structure-activity relationship study of di- and tripeptides. J. Agric. Food Chem. 2006, 54:732-738.
39. Hong F., Ming L., Yi S., Zhanxia L., Yongquan W., Chi L. The antihypertensive effect of peptides: a novel alternative drugs?. Peptides 2008, 1060-1071.
40. Tovar-Pérez E.G., Guerrero-Legarreta I., Farrés-González A., Soriano-Santos J. Angiotensin I-converting enzyme-inhibitory peptide fractions from albumin 1 and globulin as obtained of amaranth grain. Food Chem. 2009, 116:437-444.
41. Vechi B., Añon M.C. ACE inhibitory tetrapeptides from Amaranthus hypochondriacus 11S globulin. Phytochemistry 2009, 70:864-870.
42. Ashab I., Peer G., Blum M., Wollman Y., Chernihovsky T., Hassner A., Schwartz D., Cabili Sh., Silverberg D., Iaina A. Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production. Kidney Internat. 1995, 47:1515-1521.
43. Garvey E.P., Oplinger J.A., Furfine E.S., Kiff R.J., Laszlo F., Whittle B.J.R., Knowles R.G. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 1997, 272:4959-4963.
44. Huang S.S., Mashino T., Mochizuki M., Chiang L.Y., Chih L.H., Hseih H.M., M Teng C., Okuda K., Hirota T., Tsai M.C. Effect of hexasulfobutylated C(60) on the isolated aortic ring of guinea pig. Pharmacology 2002, 64:91-97.
45. Strzelecka M., Bzowska M., Koziet J., Szuba B., Dubiel O., Riviera Nuñez D., Heinrich M., Bereta J. Anti-inflammatory effects of extracts from some traditional Mediterranean diet plants. J. Physiol. Pharmacol. 2005, 56:139-156.
46. Cotton J.M., Kearney M.T., Shah A.M. Nitric oxide and myocardial function in heart failure: friend or foe?. Heart 2002, 88:564-566.
47. Tripathi P., Tripathi P., Kashyap L., Singh V. The role of nitric oxide in inflammatory reactions. FEMS Immunol. Med. Microbiol. 2007, 3:440-452.
48. Espin J.C., Garcia-Conesa M.T., Tomas-Barberan F.A. Nutraceuticals: facts y fiction. Phytochemistry 2007, 68:2986-3008.
49. FitzGerald R.J., Meisel H. Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br. J. Nutr. 2000, 84(Suppl. 1):S33-S37.
50. Meisel H., FitzGerald R.J. Opioid peptides encrypted in intact milk protein sequences. Br. J. Nutr. 2000, 84:S27-S31.
51. Yang Y., Tao G., Liu P., Liu J. Peptide with angiotensin I-converting enzyme inhibitory activity from hydrolyzed corn gluten meal. J. Agric. Food Chem. 2007, 55:7891-7895.